Phase
Condition
Williams Syndrome
Manic Disorders
Treatment
Multicomponent intervention program
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
Adult ICU patients (aged ≥18) with an expected ICU stay of >24 hours
Patients who are (expected to become) agitated within the first 14 days of their ICUadmission
Exclusion
Exclusion criteria:
Contra indication for dexmedetomidine use (i.e., AV-block grade 2 or 3 unless apacemaker is present, uncontrolled hypotension, acute cerebrovascular condition orknown/suspected hypersensitivity);
Neurological patients with an (expected risk of) increased intracranial pressure;
An intoxication as a result of drug abuse (e.g., ethanol, γ-Hydroxybutyrate,opioids, benzodiazepines);
Support with Extracorporeal Membrane Oxygenation (ECMO);
Difficult airway (e.g., a Cormack and Lehane laryngoscopy grade 4 view or a tumorcausing airway obstruction);
A high risk of physical aggression towards healthcare professionals;
No consent for long term follow up in the MONITOR-IC study;
Not able to read or understand the Dutch language and no relatives able to assist;
Enrolment in other sedation studies.
Study Design
Study Description
Connect with a study center
Noordwest Ziekenhuisgroep
Alkmaar,
NetherlandsActive - Recruiting
Bravis Ziekenhuis
Bergen Op Zoom,
NetherlandsActive - Recruiting
Amphia Ziekenhuis
Breda,
NetherlandsActive - Recruiting
Zuyderland Ziekenhuis
Heerlen,
NetherlandsSite Not Available
Elkerliek Ziekenhuis
Helmond,
NetherlandsActive - Recruiting
VieCuri Medisch Centrum
Venlo,
NetherlandsActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.